Open access
78,743
Views
65
CrossRef citations to date
0
Altmetric
Research Article
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens
Georgi Momekova Lab of Experimental Chemotherapy and Molecular Pharmacology, Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaCorrespondence[email protected]
https://orcid.org/0000-0003-2841-7089
& https://orcid.org/0000-0003-2841-7089
Denitsa Momekovab Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
Pages 469-474
|
Received 16 Apr 2020, Accepted 23 May 2020, Published online: 05 Jun 2020
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.